Centre Antoine Lacassagne

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study	cancer, neoplasm	Active, not recruiting	Phase 3	2026-07-24	NCT03768063
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)	Metastatic Castrate Resistant Prostate Cancer (mCRPC)	Active, not recruiting	Phase 4	2026-07-06	NCT04597125
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, leiomyosarcoma, myomatous neoplasm, neoplasm, sarcoma	Active, not recruiting	Phase 3	2026-06-18	NCT06088290
Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence	Cutaneous Squamous Cell Carcinoma (CSCC)	Recruiting	Phase 3	2026-04-24	NCT06692556

Clinical trials